Fireside Chat: Effectively Operationalizing Clinical Trials in Immune Resetting Therapeutics

• Securing Centre’s of Excellence with necessary oncology and rheumatology clinical expertise for patient screening lymphodepletion and toxicity management
• Addressing the competitive landscape around securing sites and managing site capacity that can risk delaying trial activation and delaying patient enrolment
• Improving patient enrolment practices through streamlining the patient journey, site education and increasing the centralization of trials to be more accessible

Speakers:

Ricardo Grieshaber-Bouyer

Professor - Clinical Systems Immunology

Friedrich-Alexander- Universität Erlangen- Nürnberg

Jeffrey Jones

Chief Medical Officer

Cullinan Therapeutics